• Citer

Guidance for the prevention of bone loss and fractures in postmenopausal women treated with aromatase inhibitors for breast cancer: an ESCEO position paper.

par Rizzoli, René;Body, Jean-Jacques ;De Censi, A;Reginster, Jean-Yves;Piscitelli, P;Brandi, M L;European Society for Clinical and Economical aspects of Osteoporosis and Osteoarthritis (ESCEO),
Référence Osteoporosis international, 23, 11, page (2567-2576)
Publication Publié, 2012-11

Article révisé par les pairs

• Détails
• Contenu

Résumé :

Aromatase inhibitors (AIs) are widely used in women with breast cancer, but they are known to increase bone loss and risk of fractures. Based on available evidence and recommendations, an ESCEO working group proposes specific guidance for the prevention of AIs-induced bone loss and fragility fractures.